Donate today in loving memory of Sam Shumadine.
![Samuel Conrad Shumadine Headshot Samuel Conrad Shumadine headshot](https://osinst.org/wp-content/uploads/2024/02/Samuel-Conrad-Shumadine-Obit-Picture-e1707845068356.jpg)
Sam’s Story
Samuel Conrad Shumadine, 17, passed away on Wednesday, January 3, 2024, at home in Norfolk, Virginia following a courageous battle with osteosarcoma. Sam was diagnosed with osteosarcoma in his left tibia in April 2022 after experiencing knee pain. Sam’s cancer had already spread to his lungs at diagnosis and proved to be very aggressive and resistant to many drugs including the standard MAP protocol.
Despite facing an aggressive cancer, Sam was never defined by his illness. He always remained an engaged and active member of the Norfolk Academy community, which he joined in first grade. It immediately became his home away from home. He loved every aspect of his school experience. He enjoyed many strong relationships with faculty and staff members and appreciated the academic rigor. An avid and skillful athlete, his competitive nature shined on the tennis courts, soccer and lacrosse fields, and basketball courts on which he was always proud to compete. Even when he could no longer play, Sam supported and inspired his teammates as a manager and enthusiastic fan. He was a natural leader in and out of the classroom, most recently serving as an executive member of the Upper School Council.
Most of all, Sam treasured his friendships with his fellow classmates who challenged him to be the best and supported him when he most needed it. His optimism, kindness, mischievous smile, and boundless humor were contagious and allowed him to easily make and keep countless friends.
Outside of school, Sam was a life-long fan of the Virginia Cavaliers, the San Francisco 49ers, and the Miami Heat. Sam lived his too short life to the fullest and loved watching and discussing sports, dancing at parties, listening to all types of music, traveling around the world, being on the water, spending summers at Camp Seagull, and vacationing at Sandbridge with family.
![](https://osinst.org/wp-content/uploads/2024/02/IMG_5388.jpg)
Thank You from the Shumadine Family!
Sam requested that we donate the funds in his savings to cancer research. Our family chose to send Sam’s funds to the Osteosarcoma Institute (OSI) and to set up the Shumiestrong Osteosarcoma Science Fund at the OSI in Sam’s memory because of their commitment to osteosarcoma research. When you donate to the OSI in Sam’s memory, 100% of your gift to the OSI will support a Phase II clinical trial that is being led by Dr. Katie Janeway at the Dana-Farber Cancer Institute. Sam participated in one of her clinical trials during his treatment journey, and now our family is committed to helping advance her efforts. CLICK HERE to learn more about the trial and how how researchers are bridging gaps in precision treatment for osteosarcoma.
Shumiestrong
One of Sam’s friends came up with Shumiestrong after Sam’s diagnosis, and his friends, tennis teammates, and classmates continue to wear the navy and light blue Shumiestrong t-shirts in Sam’s memory.
Osteosarcoma Statistics
Osteosarcoma is the most common childhood bone cancer.
No new treatments have been approved for osteosarcoma patients in 40 years.
1 in 3 children with osteosarcoma will not survive.
Frequently Asked Questions
-
What is osteosarcoma?
Osteosarcoma is a type of bone cancer that originates in cells of the bone. The word “osteosarcoma” comes from the Greek words sarc, meaning fleshy substance, and oma, meaning growth. Osteo adds bone-like to the word sarcoma. It can occur anywhere along the skeleton, but the most common sites are in longer bones, for instance around the knee (distal femur and proximal tibia) and shoulder (proximal humerus).
-
How common is osteosarcoma?
Osteosarcoma is rare — only around 1,000 people are diagnosed in the United States each year. Osteosarcoma most commonly occurs in children, teenagers and young adults between the ages of 10 and 30. It is slightly more common in boys and young men. There is a peak incidence of osteosarcoma during the adolescent growth spurt. It is very rare in children under 5 years old.
-
What causes osteosarcoma?
The exact cause is still unknown. Osteosarcoma develops when healthy cells responsible for making new bone experience changes in their DNA. These DNA changes tell the cells to make abnormal bone. This results in a tumor that invades and destroys surrounding healthy bone and surrounding tissue.
-
Can osteosarcoma be prevented?
It cannot be prevented. However, there are certain risk factors to be aware of. Osteosarcoma risk factors include:
● Bone disorders (Paget’s disease and fibrous dysplasia)
● Exposure to radiation (for example, previous cancer treatment)
● Rare, inherited disorders (hereditary retinoblastoma, Bloom syndrome, Li-Fraumeni syndrome, Rothmund-Thomson syndrome and Werner syndrome) -
What are the symptoms?
People with osteosarcoma may have a variety of symptoms, including:
● Pain in and around a bone that becomes persistent and severe over time
● Swelling near a bone
● Limping and/or inability to lift or use a limb
● Bone injury/fracture from minor trauma
If you or your child is experiencing any of the above symptoms, contact your doctor. -
How is osteosarcoma diagnosed?
The diagnosis of osteosarcoma can only be definitively made with a biopsy of the affected area. Thanks to advanced imaging technology, doctors can see — with precision — where the abnormality is located in the body and help guide the biopsy. Once a biopsy confirms the diagnosis of osteosarcoma, a variety of other tests may be ordered to further determine the extent of the tumor. These may include:
● X-Ray
● Computed tomography (CT) scan
● Magnetic resonance imaging (MRI)
● Positron emission tomography (PET) scan
● Additional blood tests
-
Can osteosarcoma spread?
Yes, osteosarcoma can metastasize, or spread, to other areas of the body, most commonly to the lungs. Osteosarcoma that spreads to the lungs happens when tumor cells travel to the lungs through the bloodstream. But since our blood always travels to the lungs to provide oxygen to our blood (and not all cancers spread to the lungs first), there must be additional reasons that osteosarcoma is so prone to lung metastases. This is an area of active research.
-
What are the treatment options for osteosarcoma?
Current therapy for osteosarcoma almost always includes the combination of a standard chemotherapy treatment and surgery. Most commonly, chemotherapy is given for several months before surgery and is continued after the patient has recovered from their surgery. The type of surgery performed can vary, but usually includes limb-preservation surgery. Following recovery from surgery, patients begin physical rehabilitation as part of their recovery process.
-
What should I know about clinical trials?
Clinical trials are available, if and when a patient recurs, following standard treatment. These trials provide patients access to novel treatment methods and drug therapies that are being developed to treat osteosarcoma. Depending on your individual case, you may be eligible to participate in one. The Osteosarcoma Institute is pleased to connect you with a free and confidential clinical trial matching service. Most clinical trials for osteosarcoma include newer “targeted therapy drug” or combinations with immunotherapy.
-
What are treatment side effects?
With any cancer treatment, there are side effects. This is also true for osteosarcoma treatment. Surgery often involves use of an internal prosthesis and rarely an external prosthesis. Physical therapy will be provided as you heal to help guide rehabilitation and ensure strength and movement are regained in the safest way possible. Chemotherapy side effects can include hair loss, nausea, fatigue, weakness, loss of appetite and weight loss. These side effects will resolve when chemotherapy is completed.
-
What is the outlook for people with osteosarcoma?
The outlook depends on many factors, including the location and size of the tumor, whether the cancer has spread and the person’s age and overall health. For more information on osteosarcoma survival rates, click here.
-
Why is more research needed?
There have been no improvements in survival of osteosarcoma patients for more than 30 years. Osteosarcoma is complex, and more research is needed. For a brief history of osteosarcoma treatment, click here. Areas of research include gene therapy, targeted drug therapy and immunotherapy.